Papers: 10.1371/journal.pone.0229754

https://doi.org/10.1371/journal.pone.0229754

Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy

Cited by: 5
Author(s): Zongwei Wang, Tuo Deng, Xingbo Long, Xueming Lin, Shulin Wu, Hongbo Wang, Rongbin Ge, Zhenwei Zhang, Chin‐Lee Wu, Mary‐Ellen Taplin, Aria F. Olumi
Published: over 6 years ago

Software Mentions 1